elisabetta ferretti
Department of Experimental Medicine, Faculty of Medicine and Dentistry, Sapienza University of Rome
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
Department of Experimental Medicine, Faculty of Medicine and Dentistry, Sapienza University of Rome
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
MultiMedica Holding SpA (IRCCS)
Milan, Italy
Associate Editor
Cancer Immunity and Immunotherapy
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
Associate Editor
Hematologic Malignancies
Royal Brisbane and Women's Hospital
Brisbane, Australia
Associate Editor
Thoracic Oncology
Dartmouth College
Hanover, United States
Associate Editor
Cancer Immunity and Immunotherapy
Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center
Los Angeles, United States
Associate Editor
Genitourinary Oncology
Hospital LusĂadas Lisboa
Lisbon, Portugal
Associate Editor
Surgical Oncology
Imperial College London
London, United Kingdom
Associate Editor
Cancer Molecular Targets and Therapeutics
Radiotherapy Unit , Istituto Nazionale Tumori
Milan, Italy
Associate Editor
Radiation Oncology
School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki
Thessaloniki, Greece
Associate Editor
Molecular and Cellular Oncology
Sapienza University of Rome
Rome, Italy
Associate Editor
Cancer Genetics
University of Bologna
Bologna, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
Department of Oncology and Hematology, Sant'Orsola-Malpighi Polyclinic
Bologna, Italy
Associate Editor
Hematologic Malignancies
National Research Council (CNR)
Roma, Italy
Associate Editor
Molecular and Cellular Oncology
Cleveland Clinic Lerner College of Medicine, School of Medicine, Case Western Reserve University
Cleveland, United States
Associate Editor
Genitourinary Oncology